术前应用HER2特异性树突状细胞疫苗治疗导管原位癌患者的安全性和有效性评估

评价者: 冯喆¹, 张剑¹, 李文桦¹, 胡夕春¹, 文献合成者: 郭丽萍²

Safety and Efficacy Evaluation of HER2 Peptide-Pulsed Dendritic Cell Vaccine in Preoperative Treatment of Patients with HER2^posDuctal Carcinoma in Situ

Reviewers: FENG Zhe¹, ZHANG Jian¹, LI Wen-hua¹, HU Xi-chun¹, Literature Co-worker: GUO Li-ping²